About Us Services Careers FAQ Contact Us 0
Home Biotechnology Asia Pacific Genetic Testing Market Growth, Latest Trend Analysis and Forecast 2030
Asia Pacific Genetic Testing Market
Select Regional / Country Report
Global Asia Pacific Europe North America LAMEA

Asia Pacific Genetic Testing Market Size, Share & Trends Analysis Report By Type (Laboratory tests, Genetic tests, Tumor biomarkers tests, Imaging, endoscopy, Biopsy, Liquid biopsy, Immunohistochemistry, In situ hybridization), By Technology (Instrument based, Platform-based, Tumor biomarker tests), By Application (Breast cancer, Colorectal cancer, Cervical cancer, Lung cancer, Prostate cancer, Skin cancer, Blood cancer, Kidney cancer, Pancreatic cancer, Ovarian cancer), By End User (Cancer research institutes, Diagnostic laboratories, Hospitals) and By Country(China, Korea, Japan, India, Australia, Taiwan, South East Asia, Rest of Asia-Pacific) Forecasts, 2022-2030

Report Code: SRBI3209DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. APAC
  2. ESG Trends
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Predictive Testing & Presymptomatic Testing
        1. By Value
      3. Carrier Testing
        1. By Value
      4. Prenatal & Newborn Testing
        1. By Value
      5. Diagnostic Testing
        1. By Value
      6. Pharmacogenomic Testing
        1. By Value
      7. Others
        1. By Value
    3. By Technique
      1. Introduction
        1. Technique By Value
      2. Polymerase chain reaction (PCR)
        1. By Value
      3. DNA Sequencing
        1. By Value
      4. Cytogenetics
        1. By Value
      5. Microarrays
        1. By Value
      6. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Oncology
        1. By Value
      3. Cardiovascular Disease Diagnosis
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Genetic Disorders
        1. By Value
      6. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals & Clinics
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Others
        1. By Value
    6. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Predictive Testing & Presymptomatic Testing
          1. By Value
        3. Carrier Testing
          1. By Value
        4. Prenatal & Newborn Testing
          1. By Value
        5. Diagnostic Testing
          1. By Value
        6. Pharmacogenomic Testing
          1. By Value
        7. Others
          1. By Value
      2. By Technique
        1. Introduction
          1. Technique By Value
        2. Polymerase chain reaction (PCR)
          1. By Value
        3. DNA Sequencing
          1. By Value
        4. Cytogenetics
          1. By Value
        5. Microarrays
          1. By Value
        6. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Oncology
          1. By Value
        3. Cardiovascular Disease Diagnosis
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Genetic Disorders
          1. By Value
        6. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals & Clinics
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Asia Pacific Genetic Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. FUJIFILM Corporation
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Vela Diagnostics
    3. AMOY Diagnostics CO. LTD.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Cancer Genetic Testing Market Size The global cancer genetic testing market size was valued at USD 6.70 billion in 2024 and is projected to reach from USD 7.47 billion in 2025 to USD 17.98 billion by 2033, growing at a CAGR of 11.6% during the forec
Buy Now
Global Report
The global EMC testing market size was valued at USD 2.5 billion in 2023 and is projected to reach USD 3.8 billion by 2032, registering a CAGR of 4.9% during the forecast period (2024-2032). The global EMC testing market is growing due to increased d
Buy Now
Global Report
The global esoteric testing market size was valued at USD 25.9 billion in 2023 and is projected to reach USD 67.5 billion by 2032, registering a CAGR of 11.2% during the forecast period (2024-2032). The Esoteric Testing market growth is due to the pr
Buy Now
Global Report
Market Overview The global generative design market size is projected to reach USD 7 billion by 2030, from USD 2 billion in 2021, and is anticipated to register a CAGR of 16 % during 2022–2030. A design exploration approach is known as genera
Buy Now
Global Report
Global metabolic testing market was valued at USD 484.3 million in 2018 and is expected to grow at a CAGR of 8.3% during the forecast period 2023–2031. Metabolism includes blood circulation, breathing, digestion of food, and contraction of mus
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.